Effects of acarbose on the acceleration of postprandial hyperglycemia- induced pathological changes induced by intermittent hypoxia in lean mice

Journal of Pharmacological Sciences

Volumn 114, Issue 1, 2010, Pages 32-40

  Miyamura, Masatoshi ^a   Schnell, Oliver ^b   Yamashita, Chika ^a   Yoshioka, Toshitaka ^a   Matsumoto, Chika ^a   Mori, Tatsuhiko ^a   Ukimura, Akira ^a   Kitaura, Yasushi ^a   Matsumura, Yasuo ^a   Ishizaka, Nobukazu ^a   Hayashi, Tetsuya ^a,c  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b INSTITUT FÜR DIABETESFORSCHUNG   (Germany)

^c OSAKA MEDICAL COLLEGE HOSPITAL   (Japan)

Author keywords

Intermittent hypoxia; Oxidative stress; Postprandial hyperglycemia; Sleep apnea; glucosidase inhibitor

Indexed keywords

4 HYDROXYNONENAL; ACARBOSE; ANGIOTENSIN II; GLUCOSE; MESSENGER RNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DIET SUPPLEMENTATION; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; HYPERGLYCEMIA; HYPOXIA; LEAN BODY WEIGHT; MALE; MOUSE; MYOCARDIAL DISEASE; NONHUMAN; OXIDATIVE STRESS; POSTPRANDIAL STATE; PROTEIN EXPRESSION;

EID: 77957953067     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.10014FP     Document Type: Article

References (45)

1. Robertson RP, Harmon J, Tran PO, Poitout V. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes. 2004;53:S119-S124.
2. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes. 1999;48:1-9.
3. Horie K, Miyata T, Maeda K, Miyata S, Sugiyama S, Sakai H, et al. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J Clin Invest. 1997;100:2995-3004.
4. Azuma K, Kawamori R, Toyofuku Y, Kitahara Y, Sato F, Shimizu T, et al. Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endothelium of rat thoracic aorta. Arterioscler Thromb Vasc Biol. 2006;26:2275-2280.
5. Puls W, Keup U, Krause HP, Thomas G, Hoffmeister F. Glucosidase inhibition. A new approach to the treatment of diabetes, obesity, and hyperlipoproteinaemia. Naturwissenschaften. 1977;64:536-537.
6. Rösen P, Osmers A. Oxidative stress in young Zucker rats with impaired glucose tolerance is diminished by acarbose. Horm Metab Res. 2006;38:575-586.
7. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M; STOP-NIDDM Trial Research Group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA. 2003;290:486-494.
8. Martin JM, Carrizo SJ, Vicente E, Agusti AGN. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365:1046-1053.
9. Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA. 2004;291:2013-2016.
10. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J. 2004;25:735-741.
11. Hayashi T, Yamashita C, Matsumoto C, Kwak CJ, Fujii K, Hirata T, et al. Role of gp91phox-containing NADPH oxidase in left ventricular remodeling induced by intermittent hypoxic stress. Am J Physiol Heart Circ Physiol. 2008;294:H2197-H2203.
12. Matsumoto C, Hayashi T, Kitada K, Yamashita C, Miyamura M, Mori T, et al. Chymase plays an important role in left ventricular remodeling induced by intermittent hypoxia in mice. Hypertension. 2009;54:164-171.
13. Azuma K, Toyofuku Y, Iesaki T. Acarbose, an alpha-glucosidase inhibitor, improves endothelial dysfunction in Goto-Kakizaki rats exhibiting repetitive blood glucose fluctuation. Biochem Biophys Res Commun. 2006;345:688-693.
14. Lee SM. The effect of chronic alpha-glycosidase inhibition on diabetic nephropathy in the db/db mouse. Diabetes. 1982;31:249-254.
15. Yamashita C, Hayashi T, Mori T, Tazawa N, Kwak CJ, Nakano D, et al. Angiotensin II receptor blocker reduces oxidative stress and attenuates hypoxia-induced left ventricular remodeling in apolipoprotein E-knockout mice. Hypertens Res. 2007;30:1219-1230.
16. Nakano D, Hayashi T, Tazawa N, Yamashita C, Inamoto S, Okuda N, et al. Chronic hypoxia accelerates the progression of atherosclerosis in apolipoprotein E-knockout mice. Hypertens Res. 2005;28:837-845.
17. Okuda N, Hayashi T, Mori T, Inamoto S, Okabe M, Mieno S, et al. Nifedipine enhances the cardioprotective effect of an angiotensin- II receptor blocker in an experimental animal model of heart failure. Hypertens Res. 2005;28:431-438.
18. Einhorn D, Stewart DA, Erman MK, Gordon N, Philis-Tsimikas A, Casal E. Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus. Endocr Pract. 2007;13:355-362.
19. Strohl KP, Novak RD, Singer W, Cahan C, Boehm KD, Denko CW, et al. Insulin levels, blood pressure and sleep apnea. Sleep. 1994;17:614-618.
20. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med. 2002;165:670-676.
21. Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med. 2002;165:677-682.
22. Ceriello A, Hanefeld M, Leiter L, Monnier L, Moses A, Owens D, et al. Postprandial glucose regulation and diabetic complications. Arch Intern Med. 2004;164:2090-2095.
23. Schnell O, Standl E. Impaired glucose tolerance, diabetes, and cardiovascular disease. Endocr Pract. 2006;12:16-19.
24. Inamoto S, Hayashi T, Tazawa N, Mori T, Yamashita C, Nakano D, et al. Angiotensin-II receptor blocker exerts cardioprotection in diabetic rats exposed to hypoxia. Circ J. 2006;70:787-792.
25. Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 2008;57:1349-1354.
26. Hinojosa-Laborde C, Mifflin SW. Sex differences in blood pressure response to intermittent hypoxia in rats. Hypertension. 2005;46:1016-1021.
27. Lai CJ, Yang CC, Hsu YY, Lin YN, Kuo TB. Enhanced sympathetic outflow and decreased baroreflex sensitivity are associated with intermittent hypoxia-induced systemic hypertension in conscious rats. J Appl Physiol. 2006;100:1974-1982.
28. Troncoso Brindeiro CM, da Silva AQ, Allahdadi KJ, Youngblood V, Kanagy NL. Reactive oxygen species contribute to sleep apnea- induced hypertension in rats. Am J Physiol Heart Circ Physiol. 2007;293:H2971-H2976.
29. Zoccal DB, Bonagamba LG, Oliveira FR, Antunes-Rodrigues J, Machado BH. Increased sympathetic activity in rats submitted to chronic intermittent hypoxia. Exp Physiol. 2007;92:79-85.
30. Sawyer DB, Siwik DA, Xiao L, Pimentel DR, Singh K, Colucci WS. Role of oxidative stress in myocardial hypertrophy and failure. J Mol Cell Cardiol. 2002;34:379-388.
31. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;14:115-126.
32. Nishikawa T, Edelstein D, Du XL. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404:787-790.
33. Tan KC, Chow WS, Ai VH, Metz C, Bucala R, Lam KS. Advanced glycation end products and endothelial dysfunction in type 2 diabetes. Diabetes Care. 2002;25:1055-1059.
34. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NADPH oxidase in cultured vascular cells. Diabetes. 2000;49:1939-1945.
35. Venugopal SK, Devaraj S, Yang T, Jialal I. Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha. Diabetes. 2002;51:3049-3054.
36. Guzik TJ, Mussa S, Gastaldi D. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NADPH oxidase and endothelial nitric oxide synthase. Circulation. 2002;105:1656-1662.
37. Chen L, Einbinder E, Zhang Q, Hasday J, Balke CW, Scharf SM. Oxidative stress and left ventricular function with chronic intermittent hypoxia in rats. Am J Respir Crit Care Med. 2005;172:915-920.
38. Liao Y, Takashima S, Zhao H, Asano Y, Shintani Y, Minamino T, et al. Control of plasma glucose with alpha-glucosidase inhibitor attenuates oxidative stress and slows the progression of heart failure in mice. Cardiovasc Res. 2006;70:107-116.
39. Gao X, Belmadani S, Picchi A, Xu X, Potter BJ, Tewari-Singh N, et al. Tumor necrosis factor-alpha induces endothelial dysfunction in Leprdb mice. Circulation. 2007;115:245-254.
40. Privratsky JR, Wold LE, Sowers JR, Quinn MT, Ren J. AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT1 receptor and NADPH oxidase. Hypertension. 2003;42:206-212.
41. Calkin AC, Cooper ME, Jandeleit-Dahm KA, Allen TJ. Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation. Diabetologia. 2006;49:766-774.
42. Minoguchi K, Tazaki T, Yokoe T, Minoguchi H, Watanabe Y, Yamamoto M, et al. Elevated production of tumor necrosis factoralpha by monocytes in patients with obstructive sleep apnea syndrome. Chest. 2004;126:1473-1479.
43. Myśliński W, Dybala A, Mosiewicz J, Prystupa A, Hanzlik J. Cardiovascular abnormalities in patients with obstructive sleep apnoea syndrome. Wiad Lek. 2005;58:78-83.
44. Zakheim RM, Molteni A, Mattioli L, Park M. Plasma angiotensin II levels in hypoxic and hypovolemic stress in unanesthetized rabbits. J Appl Physiol. 1976;41:462-465.
45. Sodhi CP, Kanwar YS, Sahai A. Hypoxia and high glucose upregulate AT1 receptor expression and potentiate ANG II-induced proliferation in VSM cells. Am J Physiol Heart Circ Physiol. 2003;284:846-852.